Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA
Alexander H. Yang(University of California San Diego), Rohit Loomba(University of California San Diego), Maral Amangurbanova(University of California San Diego), Claude B. Sirlin(University of California, San Diego), Veeral Ajmera(University of California San Diego), Christian Butcher(University of California San Diego), Monica A. Tincopa(University of California San Diego), Christie Hernandez(University of California San Diego), Ricki Bettencourt(University of California San Diego), Federica Tavaglione(Università Campus Bio-Medico), Seema Singh(University of California San Diego), Bernd Schnabl(UC San Diego Health System), Lisa Richards(University of California San Diego), Egbert Madamba(University of California San Diego)
Cited by 54
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k